Lung Cancer News
Week Ending September 27, 2021

OneOncology Unveils Data Demonstrating Increased Utilization of Genomic and Biomarker Testing at Community Cancer Centers
“OneOncology, the national platform for independent community oncology practices, and Genentech, a member of the Roche Group, presented data in two abstracts at the 2021 ASCO Quality Care Symposium examining genomic profiling and biomarker testing patterns in community oncology centers, as part of their multi-year strategic research partnership.”

White Ribbon Project holds lung cancer awareness event in Woodland
“Shyreece Pompey was a school teacher and devout member of her church in Michigan prior to finding out she had lung cancer.”

Turning the Tide against Non–Small Cell Lung Cancer
“Mortality from non–small cell lung cancer (NSCLC) has sharply declined in recent years, a decrease that has coincided with a spate of FDA approvals for targeted therapies in patients whose tumors harbor various genetic alterations. In 2015, two papers in Cancer Discovery showed that MET exon 14 splice site mutations were recurrent and actionable in patients with NSCLC.”

Annabelle Gurwitch and chef Amar Santana partner with Lung Cancer Foundation of America (LCFA)
“New York Times bestselling author, actor, and activist, and former Dinner and a Movie host Annabelle Gurwitch is teaming up with celebrity chef Amar Santana to raise money for lung cancer research during a fun and delicious live, virtual cooking competition on October 2nd.”

Radiation or Surgery in Early Lung Cancer: Does It Make a Difference?
“Ablative radiation still noninferior to VATS after longer follow-up. Long-term survival was equivalent for patients with early-stage non-small-cell lung cancer (NSCLC) whether treated with stereotactic ablative radiotherapy (SABR) or surgery, according to updated results from a prospective study.”

First Patient With Lung Cancer Treated in Phase 2b Tomivosertib Trial
“The first patient was dosed in the phase 2b KICKSTART clinical trial from eFFECTOR Therapeutics, Inc. in early June. The randomized trial will treat patients who have non-small cell lung cancer (NSCLC) with a combination of tomivosertib and Keytruda (pembrolizumab).”

Lung Cancer Screening Eligibility Highlights Health Disparities
“Health disparities among racial and ethnic minorities are still present in guidelines for lung cancer screening eligibility.”

Antibody response after COVID-19 vaccination lower among some patients with lung cancer
“Most patients with lung cancer — including those receiving active therapy — produced neutralizing antibodies to COVID-19 after vaccination, according to study results.”

Durvalumab and chemotherapy effective for extensive-stage small cell lung cancer
“Durvalumab and chemotherapy in extensive stage small cell lung cancer showed an improved overall survival compared to chemotherapy alone.”

Mirati’s adagrasib scores encouraging results in KRAS-mutated lung cancer
“US biotech company Mirati Therapeutics announced positive Phase II results for its investigational treatment adagrasib as a treatment for KRAS-mutated lung cancer.”

Top Science From the World Conference on Lung Cancer
“In this podcast, we examine some of the most important studies presented at this year’s meeting”

Expert Discusses Community Adoption of Immunotherapy in Lung Cancer
“Robert Coleman, MD, FACOG, FACS, discussed how immunotherapy in lung cancer has been widely accepted and adopted in the community oncology setting.”